References
Howe JR, Merchant NB, Conrad C, et al. The North American neuroendocrine tumor society consensus paper on the surgical management of pancreatic neuroendocrine tumors. Pancreas. 2020;49(1):1–33. https://doi.org/10.1097/MPA.0000000000001454.
Feng T, Lv W, Yuan M, Shi Z, Zhong H, Ling S. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma. World J Surg Oncol. 2019;17(1):54. https://doi.org/10.1186/s12957-019-1597-5.
Haugvik SP, Janson ET, Österlund P, et al. Surgical treatment as a principle for patients with high-grade pancreatic neuroendocrine carcinoma: a Nordic multicenter comparative study. Ann Surg Oncol. 2016;23(5):1721–8. https://doi.org/10.1245/s10434-015-5013-2.
Fischer L, Bergmann F, Schimmack S, et al. Outcome of surgery for pancreatic neuroendocrine neoplasms. Published online 2014. https://doi.org/10.1002/bjs.9603.
Kaslow SR, Vitiello G, Prendergast K, et al. Surgical treatment of patients with poorly-differentiated pancreatic neuroendocrine carcinoma: an NCDB analysis. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11477-5
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kaslow, S.R., Correa-Gallego, C. ASO Author Reflections: Reconsidering Resection for Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma. Ann Surg Oncol 29, 3532–3533 (2022). https://doi.org/10.1245/s10434-022-11479-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-11479-3